
Frequently Asked Questions
Yes. Aspect mobile enables users to register samples upon collection.
- The samples are assigned a unique sample ID which can be generated by the app or use an existing sample ID (e.g. preprinted on a specimen request form).
- Once registered, the samples can be tracked (pickup, delivery at lab, etc).
- When a result comes in with a matching sample ID, Aspect automatically sends the result to the app that registered the sample (or another user authorized at that clinic).
Aspect mobile provides both visual and real-time reporting and alert components to help healthcare workers manage and act upon diagnostic results.
- Ability to transfer results to other clinics
- Icons reflecting the type of test run
- Patient ID easily searchable
- Every result shows whether it requires follow-up and if the follow-up has been confirmed
- Simple clinical response inputs – treatment initiation date and treatment protocol
- Healthcare workers can comment to explain loss to follow-up
Supervisors can manage healthcare workers' use of the app
Weekly reports can be automatically emailed to supervisors to monitor app users in their local districts
App users can track patients and confirm patients on treatment in real-time
As part of the Aspect platform, Aspect mobile can receive any results in Aspect, including but not limited to GeneXpert, MGIT, TrueLab, Abbott m2000 and others, allowing diagnostic result tracking in real-time for TB, HIV, HCV, Ebola, Zika etc.
Aspect can send any information associated with a sample or test result to or from the mobile device, including related information from APIs or Webhooks of other systems, including e-TB Manager, DISA, Open MRS, DHIS2 and OpenLDR. [PM1]
Aspect mobile was designed to work in places with intermittent web access. It can run online or offline, enabling healthcare workers to continue to do their job whether connected to the Internet or not.
Typically the Ministry of Health owns the data.
Any language can be supported by the Aspect app. Users can select a language on the login page or the user profile page. The platform is currently available in English, French, Portuguese, and Russian. Any further translations can be made possible by the development team.
